AI Article Synopsis

  • Inhaled corticosteroids (ICS) have proven to be very effective for treating asthma but show only modest benefits for COPD.
  • A study tested whether the size of bronchial airway smooth muscle cells (ASMC) in COPD patients correlates with their responsiveness to ICS.
  • Results indicated that patients with high ASMC area (HASMC) experienced significant improvements in lung function when using ICS, while those with low ASMC area (LASMC) did not show considerable benefits, suggesting that ASMC size could help predict treatment outcomes for COPD patients.

Article Abstract

Background: Although inhaled corticosteroids (ICS) are highly effective in asthma, they provide significant, but modest, clinical benefit in COPD. Here, we tested the hypothesis that high bronchial airway smooth muscle cell (ASMC) area in COPD is associated with ICS responsiveness.

Methods: In this investigator-initiated and -driven, double-blind, randomised, placebo-controlled trial (HISTORIC), 190 COPD patients, Global Initiative for Chronic Obstructive Lung Disease stage B-D, underwent bronchoscopy with endobronchial biopsy. Patients were divided into groups A and B, with high ASMC area (HASMC: >20% of the bronchial tissue area) and low ASMC area (LASMC: ≤20% of the bronchial tissue area), respectively, and followed a run-in period of 6 weeks on open-label triple inhaled therapy with aclidinium (ACL)/formoterol (FOR)/budesonide (BUD) (400/12/400 μg twice daily). Subsequently, patients were randomised to receive either ACL/FOR/BUD or ACL/FOR/placebo and followed for 12 months. The primary end-point of the study was the difference in post-bronchodilator forced expiratory volume in 1 s (FEV) over 12 months between patients with LASMC and HASMC receiving or not receiving ICS.

Results: In patients with LASMC, ACL/FOR/BUD did not significantly improve FEV over 12 months, as compared to ACL/FOR/placebo (p=0.675). However, in patients with HASMC, ACL/FOR/BUD significantly improved FEV, as compared to ACL/FOR/placebo (p=0.020). Over 12 months, the difference of FEV change between the ACL/FOR/BUD group and the ACL/FOR/placebo group was 50.6 mL·year within the group of patients with LASMC and 183.0 mL·year within the group of patients with HASMC.

Conclusion: COPD patients with ΗASMC respond better to ICS than patients with LASMC, suggesting that this type of histological analysis may predict ICS responsiveness in COPD patients receiving triple therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00218-2023DOI Listing

Publication Analysis

Top Keywords

copd patients
16
patients lasmc
16
patients
12
asmc area
12
airway smooth
8
smooth muscle
8
responsiveness copd
8
patients receiving
8
receiving triple
8
triple therapy
8

Similar Publications

Skeletal muscle dysfunction (SMD), one of the extrapulmonary complications in patients with chronic obstructive pulmonary disease (COPD), considerably influences patient prognosis. Mitochondria regulates their dynamic networks through a mitochondria quality control (MQC) mechanism, involving mitochondrial biogenesis, mitochondrial dynamics, and mitophagy. The MQC is crucial for mitochondrial homeostasis and health, and disruption of it can lead to mitochondrial damage, which is a key factor in the structural and functional impairment of skeletal muscle in COPD.

View Article and Find Full Text PDF

Aim: This study aimed to evaluate the effect of partially edentulous ()PED condition on lung function through spirometry tests and comparison of airflow rates between dentulous and PED subjects.

Settings And Design: The study design was a cross-sectional study conducted in the department of prosthodontics.

Materials And Methods: Twenty-eight dentulous and 28 PED patients with an age range of 25-50 years were included in the study.

View Article and Find Full Text PDF

This cross-sectional study aimed to investigate the role of peak inspiratory flow rate (PIFR) in the management of inhalation therapy for patients with chronic obstructive pulmonary disease (COPD). Conducted in the Department of Pulmonary Medicine at a tertiary care institute from July 2021 to January 2022, this study included a total of 351 patients who were clinically diagnosed with stable COPD and currently receiving inhaler therapy. Participants underwent comprehensive assessments that included demographic data collection, the use of the ABCD assessment tool to evaluate disease severity, the COPD Assessment Test (CAT) for quality of life measurement, and assessments for adherence to inhaler therapy and inhaler technique proficiency.

View Article and Find Full Text PDF

Background: Routine body mass index (BMI) recording in electronic health records (EHR) could support general practitioners (GPs) in managing patients with obesity. This study aimed to evaluate recording practices of BMI, overweight, and obesity in adults including subgroup analysis of age, sex, and comorbidities in primary care in the Netherlands.

Methods: An observational study of individuals aged ≥ 18 years and registered between 2007 and 2023, using routine healthcare data from the Extramural LUMC Academic Network (ELAN) in the Netherlands.

View Article and Find Full Text PDF

Climate change and air pollution are pressing public health concerns, necessitating monitoring of their impact, particularly on respiratory diseases like obstructive lung diseases. This retrospective study analyzed medical records of patients hospitalized at the Warmia and Mazury Centre for Pulmonary Diseases in Olsztyn, Poland (2012-2021) for asthma and chronic obstructive pulmonary disease (COPD) exacerbations. Data included meteorological factors such as temperature, humidity, wind speed, precipitation, and levels of PM2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!